Locally Delivered Antibiotics in Fracture-Related Infection

Henry Mills1, Liam Donnelly2, Simon Platt1

  • 1Orthopaedics, Gold Coast University Hospital, Gold Coast, AUS.

Cureus
|December 9, 2024
PubMed

Insights

Local antibiotics offer superior fracture-related infection (FRI) prevention and treatment compared to systemic methods. Biodegradable carriers are promising, with rare adverse events reported in human studies.

Area of Science:

  • Orthopaedic Trauma Surgery
  • Infectious Diseases
  • Biomaterials Science

Background:

  • Fracture-related infections (FRIs) present significant challenges in orthopaedic trauma care.
  • Current treatments primarily use systemic antibiotics, which have limitations.
  • Local antibiotic delivery offers higher tissue concentrations and fewer systemic side effects, gaining traction for FRIs.

Purpose of the Study:

  • To review current strategies and evidence for local antibiotic delivery in preventing and treating FRIs.
  • To highlight the benefits of local antibiotic delivery over systemic administration.
  • To discuss various local delivery methods and carriers, including biodegradable options.

Main Methods:

  • Review of existing literature on local antibiotic delivery for FRIs.
  • Analysis of different antibiotic delivery systems: powders, injections, and carriers (cement, bone graft, bioceramics, polymers, hydrogels).
  • Evaluation of evidence for safety and efficacy, particularly comparing biodegradable and non-absorbable carriers.

Main Results:

  • Local antibiotic delivery demonstrates good evidence for FRI prevention and treatment, especially in high-risk or severe infections.
  • Biodegradable carriers are a promising alternative to non-absorbable carriers like cement.
  • Adverse events in human studies are rare, despite theoretical concerns.

Conclusions:

  • Local antibiotic delivery is effective and safe for managing FRIs.
  • Biodegradable carriers represent an advancement in local antibiotic delivery systems.
  • Further prospective randomized controlled trials are needed to confirm safety and efficacy across diverse fracture types.